Backargenx SE Overview

argenx SE EBIT

Latest ebit for ARGX.BR: $2.4B, below the Healthcare sector average of $1.9T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$539.00M

As of Sep 30, 2026

Annual EBIT (TTM)

$2.45B
↑ 1290.97% YoY

Trailing 12 months ending Sep 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

argenx SE (ARGX.BR) FAQ

argenx SE (ARGX.BR) currently reports a EBIT of $2.4B as of September 2026. That compares with $180M in the prior-year period — up 1291.0% year over year. That is below the Healthcare sector average of $1.9T. Use the charts on this page to explore argenx SE's EBIT history and peer comparisons.

argenx SE's EBIT increased from $180M to $2.4B — a 1291.0% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

argenx SE's EBIT of $2.4B is lower than the Healthcare sector average of $1.9T. That is roughly 99.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

argenx SE reported $2.4B in EBIT as of September 2026. That compares with $180M in the prior-year period — up 1291.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $2.4B, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $1.9T. From there, open related valuation or income-statement pages for argenx SE, and consider following ARGX.BR for alerts when major investors trade the stock.

Questions & Answers